Related Experiment Video
Updated: Oct 5, 2025

Engineering Antiviral Agents via Surface Plasmon Resonance
Published on: June 14, 2022
High affinity protein surface binding through co-engineering of nanoparticles and proteins
Moumita Ray1, Giorgia Brancolini2, David C Luther1
1Department of Chemistry, University of Massachusetts, 710 North Pleasant Street, Amherst, MA 01003, USA. rotello@chem.umass.edu.
This study introduces a novel method for high-affinity nanoparticle-protein binding using co-engineered
Area of Science:
- Biomaterials Science
- Nanotechnology
- Protein Engineering
Background:
- Controlling nanoparticle-protein interactions is crucial for therapeutics and sensors.
- Current methods often rely on affinity tags, limiting versatility.
- Achieving high affinity is difficult due to dielectric screening at physiological conditions.
Purpose of the Study:
- To develop a versatile strategy for high-affinity nanoparticle-protein binding.
- To overcome limitations of dielectric screening in physiological environments.
- To enable advanced applications in nanomedicine and biosensing.
Main Methods:
- Co-engineering of nanoparticles and proteins.
- Utilizing 'supercharged' proteins for enhanced electrostatic interactions.
- Complementary charging of nanoparticles and proteins.
- Computational modeling to identify binding drivers.
Main Results:
- Achieved high-affinity nanoparticle-protein complexes.
- Demonstrated effective binding at physiologically relevant ionic strengths.
- Identified both hydrophobic and electrostatic interactions as key drivers.
Conclusions:
- Co-engineered nanoparticle-protein systems offer a robust platform for high-affinity interactions.
- This approach provides a versatile alternative to traditional tag-based methods.
- Enables new possibilities for targeted drug delivery and advanced biosensors.
More Related Videos
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
14:43Microfluidic On-chip Capture-cycloaddition Reaction to Reversibly Immobilize Small Molecules or Multi-component Structures for Biosensor Applications
Published on: September 23, 2013
Related Concept Videos
Protein-protein Interfaces
Factors Affecting Protein-Drug Binding: Drug-Related Factors
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
Factors Affecting Protein-Drug Binding: Protein-Related Factors
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
Protein-Drug Binding: Mechanism and Kinetics
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...